Standout Papers
- The biology and management of non-small cell lung cancer (2018)
- Changing Epidemiology of Small-Cell Lung Cancer in the United States Over the Last 30 Years: Analysis of the Surveillance, Epidemiologic, and End Results Database (2006)
- Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas (2017)
Immediate Impact
3 by Nobel laureates 11 from Science/Nature 58 standout
Citing Papers
H3K18 Lactylation Potentiates Immune Escape of Non–Small Cell Lung Cancer
2024 Standout
Cancer therapy with antibodies
2024 Standout
Works of Daniel Morgensztern being referenced
Phase I Study of 2- or 3-Week Dosing of Telisotuzumab Vedotin, an Antibody–Drug Conjugate Targeting c-Met, Monotherapy in Patients with Advanced Non–Small Cell Lung Carcinoma
2021
Efficacy and Safety of Rovalpituzumab Tesirine in Third-Line and Beyond Patients with DLL3-Expressing, Relapsed/Refractory Small-Cell Lung Cancer: Results From the Phase II TRINITY Study
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Daniel Morgensztern | 5239 | 4375 | 3793 | 225 | 10.0k | |
| Koji Tsuta | 4395 | 5258 | 3186 | 297 | 9.6k | |
| Andrea Ardizzoni | 8174 | 6431 | 3566 | 463 | 12.8k | |
| Massimo Roncalli | 4630 | 3240 | 3161 | 228 | 11.3k | |
| Gabriella Fontanini | 7116 | 4574 | 5227 | 312 | 13.2k | |
| Marcello Tiseo | 5018 | 5224 | 2706 | 367 | 8.2k | |
| Edward S. Kim | 5109 | 5186 | 2856 | 211 | 9.5k | |
| Patrick Pauwels | 4050 | 3077 | 4205 | 298 | 10.3k | |
| Toyoaki Hida | 7963 | 8379 | 3920 | 280 | 13.2k | |
| Patricia Keegan | 4830 | 3055 | 2001 | 140 | 9.0k | |
| Hedy L. Kindler | 8219 | 7129 | 3496 | 394 | 15.7k |
All Works
Login with ORCID to disown or claim papers
Loading papers...